University Hospital of Leipzig, Nephrologische Ambulanz
Welcome,         Profile    Billing    Logout  
 3 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wanner, Christoph
RESOLVE, NCT02823821: Randomised Evaluation of Sodium Dialysate Levels on Vascular Events

Recruiting
4
50000
Europe, Canada, RoW
Default dialysate sodium concentration of 137mmol/l, Default dialysate sodium concentration of 140mmol/l
University of Sydney, Australasian Kidney Trials Network, Australia & New Zealand Dialysis & Transplant Registry, The George Institute for Global Health, India, The George Institute for Global Health, China, Peking University People's Hospital, Institute for Clinical Evaluative Sciences, St. Michaels Hospital, University Hospital Wuerzburg, Medizinische Klinik EINS, Malaysian Society of Nephrology, Malaysian Renal Registry, Comprehensive Clinical Trials Unit, University College London
End-Stage Kidney Disease
12/24
12/24
ALIGN, NCT04573478: Atrasentan in Patients With IgA Nephropathy

Active, not recruiting
3
404
Europe, Canada, Japan, US, RoW
Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627, Placebo
Chinook Therapeutics, Inc.
IgA Nephropathy, Immunoglobulin A Nephropathy
12/26
12/26
AD(H)PKD, NCT02497521: The German ADPKD Tolvaptan Treatment Registry

Recruiting
N/A
2000
Europe
University of Cologne
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
11/25
12/27
Halbritter, Jan
EMPASTONE, NCT06653738: Trial to Assess the Efficacy of EMPAgliflozin and Personalized Dietary Counseling for Kidney STONE Prevention

Not yet recruiting
3
380
Europe
Empagliflozin 25 MG, Placebo, Personalized dietary counseling, Generic dietary counseling
Insel Gruppe AG, University Hospital Bern
Kidney Stone, Nephrolithiasis, Dietary Exposure
02/30
06/30
DOUBLE_PROTECT, NCT05944016: Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients

Recruiting
3
102
Europe
Dapagliflozin, Placebo
University Hospital Goettingen, German Research Foundation
Chronic Kidney Failure in Children and Young Adults
09/26
12/26
NCT06734234: A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease

Recruiting
1
84
Europe
GSK4771261, Placebo matching GSK4771261
GlaxoSmithKline
Kidney Disease
07/26
08/26
AD(H)PKD, NCT02497521: The German ADPKD Tolvaptan Treatment Registry

Recruiting
N/A
2000
Europe
University of Cologne
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
11/25
12/27
FOrMe, NCT03949972: The Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

Recruiting
N/A
500
Europe
Biosampling
Prof. Dr. Paul Brinkkoetter, German Research Foundation, Medical Faculty and the Faculty of Natural Sciences of the University of Cologne, Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases, Cologne Center for Genomics
Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Idiopathic Nephrotic Syndrome
03/28
03/33

Download Options